Completing data — refresh the page later to see the latest
18698-97-0O=C(O)Cc1ccccc1BrDWXSYDKEWORWBT-UHFFFAOYSA-N18698-97-0DTXSID1075149CHEMBL5400820Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H314 (10%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
P260, P261, P264, P264+P265, P271, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P319, P321, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 10 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesEmployed as a pharmaceutical intermediate. It is also used in organic synthesis.
Uses2-Bromophenylacetic acid has been used:as starting reagent in the synthesis of 8-methoxy-2-tetralonein the preparation of di-and tri-substituted 2-oxopiperazines on solid support
Preparation2-Bromophenylacetic acid can be produced by removing the sulfonic acid group through the bromination of p-sulfonophenylacetic acid and the hydrolysis of 2-bromo-4-sulfonophenylacetic acid.
Loading…